Nurix Therapeutics, Inc. - Common Stock, par value $0.001 per share (NRIX)

Historical Holders from Q3 2020 to Q1 2025

Symbol
NRIX on Nasdaq
CUSIP
67080M103
Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
75.8M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
81.1M
Holdings value
$1.53B
% of all portfolios
0.004%
Grand Portfolio weight change
+0%
Number of holders
172
Number of buys
92
Number of sells
-76
Average Value change %
+0%
Average buys %
+0.001%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Nurix Therapeutics, Inc. - Common Stock, par value $0.001 per share (NRIX)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FMR LLC 14.5% $122M 10.3M FMR LLC Nov 29, 2024
Deep Track Capital, LP 5.44% +30% $49M $13.4M 4.13M +37.5% Deep Track Capital, LP Feb 7, 2025
COMMODORE CAPITAL LP 5.1% $45.7M 3.85M COMMODORE CAPITAL LP Feb 7, 2025

Institutional Holders of Nurix Therapeutics, Inc. - Common Stock, par value $0.001 per share (NRIX)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 371K $4.4M -$27.3K $11.88 8
2024 Q4 81.1M $1.53B +$232M $18.84 172
2024 Q3 67.6M $1.52B +$52.6M $22.47 169
2024 Q2 65M $1.36B +$344M $20.87 172
2024 Q1 48.9M $718M +$58.2M $14.70 136
2023 Q4 46M $475M -$21.3M $10.32 125
2023 Q3 44.8M $352M +$8.51M $7.86 127
2023 Q2 43.6M $435M +$11.8M $9.99 122
2023 Q1 42.3M $375M -$3.62M $8.88 118
2022 Q4 42.7M $469M +$2.14M $10.98 118
2022 Q3 42.6M $555M -$36.7M $13.03 111
2022 Q2 43.5M $551M +$51.9M $12.67 96
2022 Q1 40.1M $561M -$19.1M $14.01 108
2021 Q4 40.4M $1.17B +$25.7M $28.95 117
2021 Q3 38.9M $1.17B -$6.52M $29.96 109
2021 Q2 39.1M $1.04B -$75.6M $26.53 101
2021 Q1 41.3M $1.29B +$255M $31.09 98
2020 Q4 33.1M $1.09B +$26.9M $32.88 67
2020 Q3 31.9M $1.11B +$1.11B $34.91 64